Literature DB >> 18524770

Oligomerization of BAK by p53 utilizes conserved residues of the p53 DNA binding domain.

E Christine Pietsch1, Erin Perchiniak, Adrian A Canutescu, Guoli Wang, Roland L Dunbrack, Maureen E Murphy.   

Abstract

Genotoxic stress triggers a rapid translocation of p53 to the mitochondria, contributing to apoptosis in a transcription-independent manner. Using immunopurification protocols and mass spectrometry, we previously identified the proapoptotic protein BAK as a mitochondrial p53-binding protein and showed that recombinant p53 directly binds to BAK and can induce its oligomerization, leading to cytochrome c release. In this work we describe a combination of molecular modeling, electrostatic analysis, and site-directed mutagenesis to define contact residues between BAK and p53. Our data indicate that three regions within the core DNA binding domain of p53 make contact with BAK; these are the conserved H2 alpha-helix and the L1 and L3 loop. Notably, point mutations in these regions markedly impair the ability of p53 to oligomerize BAK and to induce transcription-independent cell death. We present a model whereby positively charged residues within the H2 helix and L1 loop of p53 interact with an electronegative domain on the N-terminal alpha-helix of BAK; the latter is known to undergo conformational changes upon BAK activation. We show that mutation of acidic residues in the N-terminal helix impair the ability of BAK to bind to p53. Interestingly, many of the p53 contact residues predicted by our model are also direct DNA contact residues, suggesting that p53 interacts with BAK in a manner analogous to DNA. The combined data point to the H2 helix and L1 and L3 loops of p53 as novel functional domains contributing to transcription-independent apoptosis by this tumor suppressor protein.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18524770      PMCID: PMC2475706          DOI: 10.1074/jbc.M710539200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  50 in total

1.  Transcriptional repression of the anti-apoptotic survivin gene by wild type p53.

Authors:  William H Hoffman; Siham Biade; Jack T Zilfou; Jiandong Chen; Maureen Murphy
Journal:  J Biol Chem       Date:  2001-11-19       Impact factor: 5.157

2.  p53 has a direct apoptogenic role at the mitochondria.

Authors:  Motohiro Mihara; Susan Erster; Alexander Zaika; Oleksi Petrenko; Thomas Chittenden; Petr Pancoska; Ute M Moll
Journal:  Mol Cell       Date:  2003-03       Impact factor: 17.970

3.  BCL-2 selectively interacts with the BID-induced open conformer of BAK, inhibiting BAK auto-oligomerization.

Authors:  Salvatore C Ruffolo; Gordon C Shore
Journal:  J Biol Chem       Date:  2003-04-29       Impact factor: 5.157

4.  Protein-protein docking with simultaneous optimization of rigid-body displacement and side-chain conformations.

Authors:  Jeffrey J Gray; Stewart Moughon; Chu Wang; Ora Schueler-Furman; Brian Kuhlman; Carol A Rohl; David Baker
Journal:  J Mol Biol       Date:  2003-08-01       Impact factor: 5.469

Review 5.  The Bcl2 family: regulators of the cellular life-or-death switch.

Authors:  Suzanne Cory; Jerry M Adams
Journal:  Nat Rev Cancer       Date:  2002-09       Impact factor: 60.716

Review 6.  The Bcl-2 protein family: sensors and checkpoints for life-or-death decisions.

Authors:  Christoph Borner
Journal:  Mol Immunol       Date:  2003-01       Impact factor: 4.407

7.  Direct activation of Bax by p53 mediates mitochondrial membrane permeabilization and apoptosis.

Authors:  Jerry E Chipuk; Tomomi Kuwana; Lisa Bouchier-Hayes; Nathalie M Droin; Donald D Newmeyer; Martin Schuler; Douglas R Green
Journal:  Science       Date:  2004-02-13       Impact factor: 47.728

8.  Regulation of transactivation-independent proapoptotic activity of p53 by FOXO3a.

Authors:  Han You; Kazuo Yamamoto; Tak Wah Mak
Journal:  Proc Natl Acad Sci U S A       Date:  2006-06-06       Impact factor: 11.205

9.  Defining the p53 DNA-binding domain/Bcl-x(L)-binding interface using NMR.

Authors:  Andrew M Petros; Angelo Gunasekera; Nan Xu; Edward T Olejniczak; Stephen W Fesik
Journal:  FEBS Lett       Date:  2004-02-13       Impact factor: 4.124

10.  The codon 72 polymorphic variants of p53 have markedly different apoptotic potential.

Authors:  Patrick Dumont; J I-Ju Leu; Anthony C Della Pietra; Donna L George; Maureen Murphy
Journal:  Nat Genet       Date:  2003-02-03       Impact factor: 38.330

View more
  51 in total

1.  The cancer-associated K351N mutation affects the ubiquitination and the translocation to mitochondria of p53 protein.

Authors:  Michela Muscolini; Elisa Montagni; Vanessa Palermo; Silvia Di Agostino; Wei Gu; Salma Abdelmoula-Souissi; Cristina Mazzoni; Giovanni Blandino; Loretta Tuosto
Journal:  J Biol Chem       Date:  2011-09-27       Impact factor: 5.157

2.  Cancer-associated p53 tetramerization domain mutants: quantitative analysis reveals a low threshold for tumor suppressor inactivation.

Authors:  Rui Kamada; Takao Nomura; Carl W Anderson; Kazuyasu Sakaguchi
Journal:  J Biol Chem       Date:  2010-10-26       Impact factor: 5.157

Review 3.  Tumor suppressor p53 and estrogen receptors in nuclear-mitochondrial communication.

Authors:  Nadi T Wickramasekera; Gokul M Das
Journal:  Mitochondrion       Date:  2013-10-29       Impact factor: 4.160

4.  "Licensed to kill": tyrosine dephosphorylation and Bak activation.

Authors:  Joanna Fox; Abul Azad; Ferina Ismail; Alan Storey
Journal:  Cell Cycle       Date:  2011-02-15       Impact factor: 4.534

5.  Intracellular displacement of p53 using transactivation domain (p53 TAD) specific nanobodies.

Authors:  Anneleen Steels; Adriaan Verhelle; Olivier Zwaenepoel; Jan Gettemans
Journal:  MAbs       Date:  2018-09-11       Impact factor: 5.857

Review 6.  The p53 family and programmed cell death.

Authors:  E C Pietsch; S M Sykes; S B McMahon; M E Murphy
Journal:  Oncogene       Date:  2008-10-27       Impact factor: 9.867

7.  Outcome of a workshop on applications of protein models in biomedical research.

Authors:  Torsten Schwede; Andrej Sali; Barry Honig; Michael Levitt; Helen M Berman; David Jones; Steven E Brenner; Stephen K Burley; Rhiju Das; Nikolay V Dokholyan; Roland L Dunbrack; Krzysztof Fidelis; Andras Fiser; Adam Godzik; Yuanpeng Janet Huang; Christine Humblet; Matthew P Jacobson; Andrzej Joachimiak; Stanley R Krystek; Tanja Kortemme; Andriy Kryshtafovych; Gaetano T Montelione; John Moult; Diana Murray; Roberto Sanchez; Tobin R Sosnick; Daron M Standley; Terry Stouch; Sandor Vajda; Max Vasquez; John D Westbrook; Ian A Wilson
Journal:  Structure       Date:  2009-02-13       Impact factor: 5.006

8.  Hypoxia inactivates the VHL tumor suppressor through PIASy-mediated SUMO modification.

Authors:  Qiliang Cai; Suhbash C Verma; Pankaj Kumar; Michelle Ma; Erle S Robertson
Journal:  PLoS One       Date:  2010-03-16       Impact factor: 3.240

9.  Comparative Analyses of Transcriptional Profiles in Mouse Organs Using a Pneumonic Plague Model after Infection with Wild-Type Yersinia pestis CO92 and Its Braun Lipoprotein Mutant.

Authors:  Cristi L Galindo; Scott T Moen; Elena V Kozlova; Jian Sha; Harold R Garner; Stacy L Agar; Ashok K Chopra
Journal:  Comp Funct Genomics       Date:  2010-01-20

10.  Decrease of mitochondrial p53 during late apoptosis is linked to its dephosphorylation on serine 20.

Authors:  Cédric Castrogiovanni; Marie Vandaudenard; Béranger Waterschoot; Olivier De Backer; Patrick Dumont
Journal:  Cancer Biol Ther       Date:  2015       Impact factor: 4.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.